Professor of Medicine and Public Health at the University of Alabama at Birmingham (UAB);
Director of the UAB STD Diagnostics Laboratory;
President of the International Society for STD Research
BIOGRAPHY
MAR 06, 2024 10:00 AM PST
Breaking Barriers in STI Clinical Management: Addressing Resistance Challenges and Incorporating New Diagnostic Approaches
Speakers
-
William Geisler, M.D., M.P.H
Professor of Medicine and Epidemiology in the Division of Infectious Diseases at the University of Alabama at Birmingham (UAB); Director of the UAB STD Program; Research Director of the UAB Diagnostics Mycoplasma Laboratory; UAB Assistant Dean for Physician Scientist DevelopmentBIOGRAPHY
Event Date & Time
Date: March 6, 2024
Time: 10:00 AM (PST), 1:00 PM (EST), 7:00 PM (CET)
Abstract
Join us for a thought-provoking webinar titled, "Breaking Barriers in STI Clinical Management: Addressing Resistance Challenges and Incorporating New Diagnostic Approaches," featuring two distinguished speakers at the forefront of research and clinical practice of sexually transmitted infections (STIs). With a combined experience of over 60 years, Dr. Van Der Pol and Dr. William Geisler will share their insights on crucial aspects of STI clinical management, focusing on addressing resistance challenges and incorporating new diagnostic approaches.
This webinar aims to equip healthcare professionals with the knowledge to recognize key clinical manifestations of common curable STIs. The speakers will delve into the prevalence of antibiotic resistance mutations in Mycoplasma genitalium and Neisseria gonorrhoeae across diverse populations, shedding light on the implications of tailored treatment strategies.
Participants will gain familiarity with a range of options for STI molecular tests, including those supporting Resistance Guided Therapy. The speakers' expertise will provide valuable perspectives on the latest diagnostic technologies available for effective STI management. Join us in an engaging session that promises to enhance your understanding of the evolving landscape of STI clinical management.
Learning Objectives
- Recognize the key clinical manifestations of common curable STIs
- Understand differences in prevalence of antibiotic resistance mutations in Mycoplasma genitalium and Neisseria gonorrhoeae in different populations
- Be familiar with options for STI molecular tests, including those that can support Resistance Guided Therapy
- Review recommended testing and treatment approaches for common curable STIs
Webinars will be available for unlimited on-demand viewing after the live event.
You May Also Like
DEC 10, 2024 | 9:00 AM
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
OCT 02, 2024 | 7:30 AM
De novo gene synthesis and protein expression are established technologies that can give access to nearly any target DNA or protein sequence, allowing for engineering of biologics. In this p...
Loading Comments...